Amanote Research

Amanote Research

    RegisterSign In

New Drug Option for Men With Aggressive Prostate Cancer

Cancer - United States
doi 10.1002/cncr.31753
Full Text
Open PDF
Abstract

Available in full text

Categories
Cancer ResearchOncology
Date

October 1, 2018

Authors
Carrie Printz
Publisher

Wiley


Related search

Nine-Year Prostate Cancer Survival Differences Between Aggressive Versus Conservative Therapy in Men With Advanced and Metastatic Prostate Cancer

Cancer
Cancer ResearchOncology
2018English

Mutational Profile of Aggressive, Localised Prostate Cancer From African Caribbean Men Versus European Ancestry Men

European Urology
Urology
2019English

The PROMIS of a New Diagnostic Pathway for Men With Suspected Prostate Cancer

Clinical Oncology
Nuclear MedicineRadiologyImagingOncology
2017English

Ailanthone: A New Potential Drug for Castration-Resistant Prostate Cancer

Chinese Journal of Cancer
2017English

Hypofractionation and Prostate Cancer: A Good Option for Africa?

South African Journal of Oncology
2017English

Prostate Cancer Organoids: A Potential New Tool for Testing Drug Sensitivity

Expert Review of Anticancer Therapy
OncologyPharmacology
2015English

Metformin and Prostate Cancer: A New Role for an Old Drug

Current Urology Reports
MedicineUrology
2017English

Do New Zealand Men With Prostate Cancer Benefit From a Mediterranean-Style Diet?

2015English

Aggressive Variants of Castration-Resistant Prostate Cancer

Clinical Cancer Research
Cancer ResearchOncology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy